Clinical characteristics of Kaposiform lymphangiomatosis: a report of 8 cases
10.3760/cma.j.issn.0529-5815.2019.12.010
- VernacularTitle: 卡波西样淋巴管瘤病八例临床分析
- Author:
Tong QIU
1
;
Kaiying YANG
1
;
Suhua PENG
1
;
Shiyi DAI
1
;
Siyuan CHEN
2
;
Yi JI
1
Author Information
1. Department of Pediatric Surgery, West China Hospital, Sichuan University, Chengdu 610041, China
2. Department of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu 610041, China
- Publication Type:Journal Article
- Keywords:
Lymphangioma;
Clinical characteristics;
Treatment;
Prognosis
- From:
Chinese Journal of Surgery
2019;57(12):921-926
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the clinical symptoms, treatment intervention and prognosis of Kaposiform lymphangiomatosis(KLA).
Methods:Medical information and clinical characteristics data of 8 KLA patients who were admitted to Department of Pediatric Surgery of West China Hospital of Sichuan University from January 2016 to February 2019 were retrospectively reviewed and analyzed. There were 5 males and 3 females with age of 5.8 years old (from 8 months to 29 years old).
Results:The lesions in all patients were diffusely distributed. In all 8 patients, the lung and mediastinum were involved with different degrees. Three cases had lesions involving pelvic and abdominal organs. Three cases had lesions involving bones. One case simultaneously involved pelvic and abdominal organs, and 1 case was involved laryngeal and neck. The clinical characteristics were mainly respiratory symptoms. In the laboratory tests, 6 patients had different degrees of thrombocytopenia (minimum 3 × 109/L), and 4 patients had severe fibrinogen reduction (minimum 0.42 g/L). Three patients had prolonged activated partial thromboplastin time (up to 64.2 seconds) and 3 patients had prolonged prothrombin time (up to 18.6 seconds). After surgery (including thoracotomy, chest tube, pericardiocentesis, splenectomy) and empiric medicine therapy (vincristine, sirolimus and corticosteroid), the symptoms improved in 1 case, 2 cases died of complications, 2 cases were stable and 3 cases progressed up to February 2019.
Conclusions:KLA is a rare disease that should be differentiated from other types of vascular diseases. Currently, there is no consensus treatment guidelines exist. Accurate diagnosis in KLA can be a challenge. The situation in patients with KLA is prone to rapid deterioration and progress. Future research efforts should seek to develop target-specific drugs for KLA.
